Skip to navigation Skip to content

Participate in a Clinical Trial

Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.

Clinical Trials in MS

The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

Read more

Read more

Posting a Trial

If you would like us to post a study on these pages, please email to find out what information you need to submit for review.


Clinical trials help to determine if treatments are safe and effective. Studies are monitored to ensure that the rights and safety of all participants are protected. Make an informed decision before agreeing to participate. Read more in our Guide to Participating in Clinical Trials.

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

  1. Clinical Trial: iQool My MS

    A double-blind, placebo controlled trial to determine the effect of a tissue-selective estrogen modulator (TSEC) on tolerability and menopausal symptoms in perimenopasual women with multiple sclerosis. Study Site UCSF Medical Center, San Francisco, CA
  2. Clinical Trial: Gilenya (fingolimod)

    The purpose of this study is to monitor the safety of fingolimod and other disease-modifying treatments in patients with relapsing multiple sclerosis under conditions of routine medical practice   UPDATE 17 June 2016 The study has finished enrolling participants with med...
  3. Clinical Trial: ublituximab

    Investigators at seven sites in the United States are recruiting at least 24 (at most 100) people with relapsing MS for a study of ublituximab (TG Therapeutics, Inc.), an experimental monoclonal antibody administered via intravenous infusion. Participants are initially randoml...
  4. Clinical Trial: People with MS using medical marijuana

    Investigators are recruiting people with MS who are using medical marijuana (it will not be provided to participants) to determine the effectiveness of medical marijuana use for the management of symptoms (fatigue, mobility) in people with MS. Click here for a screening for...
  5. Clinical Trial: Arbaclofen extended release tablets

    Researchers are recruiting men with MS and spasticity to determine the effects of Arbaclofen extended release tablets on sperm.
  6. Clinical Trial: ALKS 8700

    A phase 3 open label study to evaluate the long term safety and tolerability of ALKS-8700 in adults with Relapsing and Remitting Multiple Sclerosis.
  7. Clinical Trial: Effect of Maximal Strength training on Gait and balance in persons with MS

    Subjects will undergo weight training using relatively high weights and low repetitions to determine the effect of this type of training on gait endurance, balance, and fatigue.
  8. Clinical Trial: Effect of Intermittent vs Continuous walking on gait kinematics in persons with MS

    Previous studies have shown that persons with MS have better gait endurance and less fatigue if they practice walking intermittently rather than continuously. The purpose of this study is to determine what is the difference in gait characteristics between intermittent and con...
  9. Clinical Trial: Free from Falls Online, An online fall prevention program for people with MS

    Do you have multiple sclerosis? Have you fallen in the past two months? If so, you may be eligible to participate in an study using an online education and exercise program specifically designed to reduce falls in people with multiple sclerosis. Who: People with multip...
  10. Clinical Trial: Ocrelizumab

    An open-label study to evaluate the effectiveness and safety of ocrelizumab in patients with relapsing remitting multiple sclerosis who have had a sub-optimal response to an adequate course of disease-modifying treatment.


Learn About Clinical Trials

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Contact Us

Contact Us
Newly Diagnosed
If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Start Here